pramipexole has been researched along with Memory Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buonvicino, D; Cherchi, F; Chiarugi, A; Coppi, E; Fusco, I; Giovannini, MG; Iovino, L; Lana, D; Muzzi, M; Pugliese, AM; Ranieri, G; Urru, M | 1 |
| Bennett, J; Boscolo, A; Jevtovic-Todorovic, V; Ori, C; Wiltgen, B | 1 |
| Edelstyn, NM; Ellis, SJ; Mayes, AR; Shepherd, TA | 1 |
| Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY | 1 |
4 other study(ies) available for pramipexole and Memory Disorders
| Article | Year |
|---|---|
Dexpramipexole enhances hippocampal synaptic plasticity and memory in the rat.
Topics: Aging; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Neuronal Plasticity; Neurons; Nootropic Agents; Potassium Channel Blockers; Potassium Channels; Pramipexole; Random Allocation; Rats, Wistar; Scopolamine; Tissue Culture Techniques | 2018 |
Mitochondrial protectant pramipexole prevents sex-specific long-term cognitive impairment from early anaesthesia exposure in rats.
Topics: Anesthetics, General; Animals; Animals, Newborn; Antioxidants; Benzothiazoles; Cognition Disorders; Drug Evaluation, Preclinical; Female; Male; Maze Learning; Memory Disorders; Mitochondria; Neuroprotective Agents; Pramipexole; Rats; Rats, Sprague-Dawley; Sex Factors | 2013 |
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
Topics: Aged; Attention; Benzothiazoles; Case-Control Studies; Dopamine Agonists; Female; Humans; Indoles; Male; Memory Disorders; Memory, Short-Term; Mental Recall; Middle Aged; Parkinson Disease; Pramipexole; Recognition, Psychology | 2013 |
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome | 2009 |